PHP
IONS icon

Parkman Healthcare Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Parkman Healthcare Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-161,705
Closed -$7.71M – 100
2024
Q2 		$7.71M Buy
161,705
+20,206
+14% +$829K 1.03% 39
2024
Q1 		$6.13M Sell
141,499
-69,901
-33% -$3.33M 0.75% 46
2023
Q4 		$10.7M Buy
211,400
+51,897
+33% +$2.49M 1.51% 22
2023
Q3 		$7.24M Buy
159,503
+6,451
+4% +$266K 1.33% 26
2023
Q2 		$6.28M Buy
153,052
+1,891
+1% +$72.7K 1.09% 28
2023
Q1 		$5.4M Buy
151,161
+10,046
+7% +$377K 1.18% 33
2022
Q4 		$5.33M Sell
141,115
-100,830
-42% -$4.24M 1.42% 23
2022
Q3 		$10.7M Buy
241,945
+67,645
+39% +$2.85M 3.04% 8
2022
Q2 		$6.45M Buy
+174,300
New +$6.57M 2.38% 15
2022
Q1 		– Sell
-80,238
Closed -$2.44M – 87
2021
Q4 		$2.44M Sell
80,238
-56,142
-41% -$1.77M 0.54% 49
2021
Q3 		$4.57M Hold
136,380
– – 1.16% 28
2021
Q2 		$5.44M Buy
136,380
+30,583
+29% +$1.2M 1.19% 32
2021
Q1 		$4.76M Buy
105,797
+30,379
+40% +$1.69M 1.1% 29
2020
Q4 		$4.26M Buy
+75,418
New +$3.76M 1.09% 36

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return

Parkman Healthcare Partners's IONS Position: Q3 2024 in Review

Parkman Healthcare Partners sold out of Ionis Pharmaceuticals (IONS) in Q3 2024, closing a stake of 161,705 shares — an estimated $7.71M sold.

Parkman Healthcare Partners first reported a position in IONS in Q4 2020 and held it in 14 quarters. The position peaked at $10.7M in Q3 2022. 354 funds tracked by Wall St. Rank hold IONS as of Q3 2024.

  • Parkman Healthcare Partners reported no remaining Ionis Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 161,705 Ionis Pharmaceuticals shares in Q3 2024, an estimated $7.71M.
  • Parkman Healthcare Partners first reported a position in Ionis Pharmaceuticals in Q4 2020 and held it in 14 quarters.
  • Parkman Healthcare Partners's Ionis Pharmaceuticals position peaked at $10.7M in Q3 2022.
  • 354 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2024.

Based on Parkman Healthcare Partners's 13F filing for Q3 2024, filed 14 Nov 2024.